Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.48 USD | -0.44% | -4.70% | +4.41% |
04-01 | Liquidia Says US FDA Cleared to Approve Yutrepia to Treat Hypertension | MT |
04-01 | Liquidia's Yutrepia Cleared for Potential FDA Approval Following Court Ruling | DJ |
Business Summary
Number of employees: 145
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical Products
100.0
%
| 16 | 100.0 % | 17 | 100.0 % | +9.75% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 16 | 100.0 % | 17 | 100.0 % | +9.75% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Roger Jeffs
CEO | Chief Executive Officer | 62 | 20-11-17 |
Michael Kaseta
DFI | Director of Finance/CFO | 48 | 20-11-29 |
Rajeev Saggar
CTO | Chief Tech/Sci/R&D Officer | 50 | 22-07-17 |
Damian deGoa
BRD | Director/Board Member | 45 | 20-12-13 |
Scott Moomaw
PRN | Corporate Officer/Principal | 54 | 20-11-17 |
General Counsel | 49 | 21-02-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Arthur Kirsch
BRD | Director/Board Member | 72 | 20-06-27 |
Joanna Horobin
BRD | Director/Board Member | 69 | 20-06-27 |
Roger Jeffs
CEO | Chief Executive Officer | 62 | 20-11-17 |
Stephen Bloch
CHM | Chairman | 62 | 20-06-27 |
Paul Manning
BRD | Director/Board Member | 68 | 20-11-17 |
Raman Singh
BRD | Director/Board Member | 53 | 20-06-27 |
David Johnson
BRD | Director/Board Member | 41 | 21-04-12 |
Director/Board Member | 61 | 20-06-27 | |
Damian deGoa
BRD | Director/Board Member | 45 | 20-12-13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 76,027,776 | 66,601,010 ( 87.60 %) | 0 | 87.60 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.41% | 953M | |
+25.98% | 661B | |
+26.82% | 566B | |
-6.18% | 352B | |
+20.66% | 332B | |
+3.87% | 283B | |
+14.36% | 231B | |
+5.21% | 200B | |
-8.92% | 195B | |
-5.04% | 145B |
- Stock Market
- Equities
- LQDA Stock
- Company Liquidia Corporation